Cargando…
Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis
Patients with liver cirrhosis and hepatocellular carcinoma (HCC) are often ineligible for resection or local ablation therapy due to poor liver function and/or difficult location. The aim of this study is to evaluate therapeutic outcomes of stereotactic body radiotherapy (SBRT) combined with transar...
Autores principales: | Jun, Baek Gyu, Kim, Sang Gyune, Kim, Young Don, Cheon, Gab Jin, Han, Koon Hee, Yoo, Jeong-Ju, Kim, Young Seok, Jeong, Soung Won, Jang, Jae Young, Lee, Sae Hwan, Park, Suyeon, Kim, Hong Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209230/ https://www.ncbi.nlm.nih.gov/pubmed/30379885 http://dx.doi.org/10.1371/journal.pone.0206381 |
Ejemplares similares
-
Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization
por: Baek, Min Young, et al.
Publicado: (2019) -
Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Jeong, Shin Ok, et al.
Publicado: (2017) -
Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
por: Park, Kil Hyo, et al.
Publicado: (2015) -
Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma
por: Song, Jeong Eun, et al.
Publicado: (2017) -
Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis
por: Choi, Byung Ock, et al.
Publicado: (2008)